Generics prices 'unsustainably low' in Europe, industry group says

A group representing the industry that supplies more than 60% of Europe’s medicines has hit out at the low prices being paid for these drugs.

Medicines for Europe acts on behalf of manufacturers of generics and biosimilars, and stresses to European governments, institutions and the media the role that these drugmakers play in reducing drug prices and increasing access to patients.

"A shrinking number of suppliers is recognized by the European Medicines Agency as posing a risk of medicine shortages"